entertainment -WSS

entertainment

author：hotspot 2025-10-02 00:41:36 - browse：64537

Eli Lilly headquarters — Kristoffer Tripplaar/AP

The drug giant Eli Lilly said Thursday that its diabetes drug Mounjaro helped patients with the condition lose 15.7% of their body weight in a clinical trial, a result that Wall Street analysts expect to pave the way for the therapy’s approval as a weight loss treatment.

Mounjaro is the latest drug in a class known as GLP-1s or incretins — the same class as Novo Nordisk’s Ozempic, which has become a sensation because of its ability to help patients lose weight. Mounjaro has shown the potential to lead to even greater weight loss than Ozempic, and industry experts expect that it will eventually generate many billions of dollars in annual sales. Analysts at SVB Securities projected in December that Mounjaro sales could reach $26.4 billion by 2030.

Eli Lilly on Thursday also announced quarterly earnings of $1.64 per share, adjusted for one-time items, slightly below analyst expectations, on sales of $6.96 billion. Sales were hurt because of a comparison to a year ago, when the company’s Covid-19 monoclonal antibodies were still on the market. Mounjaro sales for the first quarter were $586 million, largely for people with diabetes, compared to an analyst consensus of $433.2 million.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： 4 missing after record

WSS

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Where does female orgasm come from? Scientists think they know

Statins reduce cardiovascular risk in people living with HIV

4 missing after record

Sophia Smith scores twice for US in in 3

Ed Silverman on new gene therapies, biosimilars, coffee, and more

leisure time

entertainment

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How a key Senate committee is planning to regulate PBMs

Medicare details structure of new drug price negotiation program

Malaysia cuts short music fest after British band slams anti

Activists slam private health insurers over coverage restrictions

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Jerome Adams on the need for new antivirals for Covid

Antivenom research: Lessons from HIV applied in search for universal antidote

Sports medicine is finally prioritizing gender equality

https://cbu01.alicdn.com/img/ibank/2016/358/789/3434987853_562717485.220x220xz.jpg

hotspot

Medicare inequities exacerbate Puerto Rico’s health disparities

STAT readers on older presidents, polypills, Medicare, and more

Novartis develops a rapidly manufactured CAR

Severe heat forecast: Where scorching temperatures will persist over the next week

FAMU bans football players from facility after release of rap video shot in team's locker room

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

hotspot

hotspot

focus

leisure time